Adipocyte Therapeutics Inc is categorized under Noncommercial Research Organizations in Fremont, CA and active since 2011.
Adipocyte Therapeutics Inc was established in 2011, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Noncommercial Research Organizations business, which does work in the B2B market, and is classified as a Noncommercial Research Organizations, under code number 541720 by the NAICS.
If you are seeking more information, feel free to contact Uday Devanaboyina at the company’s single location by writing to 34313 Xanadu Terrace, Fremont, California CA 94555 or by phoning (510) 713-7112. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Adipocyte Therapeutics Inc |
| Contact Person: | Uday Devanaboyina |
| Address: | 34313 Xanadu Terrace, Fremont, California 94555 |
| Phone Number: | (510) 713-7112 |
| Annual Revenue (USD): | $50.000 to $99.999 |
| Founded: | 2011 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Noncommercial Research Organizations |
| SIC Code: | 8733 |
| NAICS Code: | 541720 |
| Share This Business: |
Adipocyte Therapeutics Inc was started in 2011 to provide professional Noncommercial Research Organizations under the SIC code 8733 and NAICS code 541720. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.
Feel free to contact Uday Devanaboyina for inquiries that concern Adipocyte Therapeutics Inc by calling the company number (510) 713-7112, as your correspondence is most welcome. Additionally, the physical location of the single location of Adipocyte Therapeutics Inc can be found at the coordinates 37.562151,-122.0545 as well as the street address 34313 Xanadu Terrace in Fremont, California 94555.
For its online presence, you may visit Adipocyte Therapeutics Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.